Gabriel Leung, Director at NovoCure Ltd (NVCR), sold 964 shares at $23.89 ($23K) on 2024-06-04, disclosed to the SEC on 2024-06-06.
Seasonal sale ($23k) by Director — this insider has traded NVCR in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| NVCR | SELL | 2021-08-06 | $153K | — | Filing → |
| NVCR | SELL | 2021-07-08 | $184K | — | Filing → |
| NVCR | SELL | 2021-06-08 | $205K | — | Filing → |